Safety and Durability of Sirolimus for Treatment of LAM

ClinicalTrials.gov ID: NCT02432560

Public ClinicalTrials.gov record NCT02432560. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 6:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter International Durability and Safety of Sirolimus in LAM Trial (MIDAS)

Study identification

NCT ID: NCT02432560
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: University of Cincinnati; Other
Enrollment: 600 participants

Conditions and interventions

Conditions

Lymphangioleiomyomatosis

Interventions

Everolimus Drug
Sirolimus Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 28, 2015
Primary completion: Jul 30, 2025
Completion: Jul 30, 2025
Last update posted: Dec 23, 2024

2015 – 2025

United States locations

U.S. sites: 20
U.S. states: 18
U.S. cities: 20

Facility	City	State	ZIP	Site status
Stanford University Medical Center	Stanford	California	94305	Recruiting
National Jewish Health	Denver	Colorado	80206	Recruiting
Mayo Clinic Jacksonville	Jacksonville	Florida	32224	Recruiting
Emory University School of Medicine	Atlanta	Georgia	33136	Recruiting
Loyola University Medical Center, Chicago	Maywood	Illinois	60153	Active, not recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Recruiting
University of Michigan	Ann Arbor	Michigan	48109	Recruiting
Mayo Clinic Rochester	Rochester	Minnesota	55905	Active, not recruiting
Washington University School of Medicine	St Louis	Missouri	63110	Recruiting
University of Rochester Medical Center	Rochester	New York	14642-8692	Recruiting
University of Cincinnati	Cincinnati	Ohio	45267	Active, not recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Active, not recruiting
Oregon Health and Science University	Portland	Oregon	97239	Active, not recruiting
University of Pennsylvania Medical Center	Philadelphia	Pennsylvania	19104	Active, not recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Active, not recruiting
Vanderbilt University Medical Center	Nashville	Tennessee	37232-2650	Active, not recruiting
University of Texas Southwestern Medical Center	Dallas	Texas	75390	Active, not recruiting
University of Texas Health Center	Houston	Texas	77030	Active, not recruiting
University of Utah School of Medicine	Salt Lake City	Utah	84132	Active, not recruiting
Swedish Medical Center	Seattle	Washington	98104	Active, not recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02432560, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 23, 2024 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02432560 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →